drugset / Trial / NCT02570412

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

NCT02570412

Expanded access No longer available CytRx

Summary

Compassionate use of aldoxorubicin in sarcoma patients who have failed prior chemotherapy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aldoxorubicin Small molecule 350 mg/m2

Indications